Artificial Intelligence (AI) in healthcare marks a new era of innovation and efficiency, characterized by the emergence of sophisticated language models such as ChatGPT (OpenAI, San Francisco, CA, USA), Gemini Advanced (Google LLC, Mountain View, CA, USA), and Co-pilot (Microsoft Corp, Redmond, WA, USA). This review explores the transformative impact of these AI technologies on various facets of healthcare, from enhancing patient care and treatment protocols to revolutionizing medical research and tackling intricate health science challenges. ChatGPT, with its advanced natural language processing capabilities, leads the way in providing personalized mental health support and improving chronic condition management. Gemini Advanced extends the boundary of AI in healthcare through data analytics, facilitating early disease detection and supporting medical decision-making. Co-pilot, by integrating seamlessly with healthcare systems, optimizes clinical workflows and encourages a culture of innovation among healthcare professionals.
Additionally, the review highlights the significant contributions of AI in accelerating medical research, particularly in genomics and drug discovery, thus paving the path for personalized medicine and more effective treatments. The pivotal role of AI in epidemiology, especially in managing infectious diseases such as COVID-19, is also emphasized, demonstrating its value in enhancing public health strategies. However, the integration of AI technologies in healthcare comes with challenges. Concerns about data privacy, security, and the need for comprehensive cybersecurity measures are discussed, along with the importance of regulatory compliance and transparent consent management to uphold ethical standards and patient autonomy. The review points out the necessity for seamless integration, interoperability, and the maintenance of AI systems' reliability and accuracy to fully leverage AI's potential in advancing healthcare.